FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

443087004: Saxagliptin (substance)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2010. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
2834307019 Saxagliptin (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
2840308015 Saxagliptin en Synonym Active Entire term case insensitive SNOMED CT core module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Saxagliptin Is a Substance with dipeptidyl peptidase IV inhibitor mechanism of action true Inferred relationship Existential restriction modifier
Saxagliptin Is a Oral hypoglycemic false Inferred relationship Existential restriction modifier
Saxagliptin Has disposition Dipeptidyl peptidase IV inhibitor true Inferred relationship Existential restriction modifier
Saxagliptin Is a Chemical categorized functionally false Inferred relationship Existential restriction modifier
Saxagliptin Is a Substance with enzyme inhibitor mechanism of action false Inferred relationship Existential restriction modifier
Saxagliptin Is a Substance with alcohol structure true Inferred relationship Existential restriction modifier
Saxagliptin Is a Nitrile true Inferred relationship Existential restriction modifier
Saxagliptin Is a Drug or medicament true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely saxagliptin 2.5 milligram/1 each conventional release oral tablet Has active ingredient False Saxagliptin Inferred relationship Existential restriction modifier
Product containing precisely saxagliptin 5 milligram/1 each conventional release oral tablet Has active ingredient False Saxagliptin Inferred relationship Existential restriction modifier
Product containing saxagliptin Has active ingredient True Saxagliptin Inferred relationship Existential restriction modifier 1
Product containing precisely metformin hydrochloride 500 milligram and saxagliptin (as saxagliptin hydrochloride) 5 milligram/1 each prolonged-release oral tablet (clinical drug) Has active ingredient False Saxagliptin Inferred relationship Existential restriction modifier
Product containing precisely metformin hydrochloride 1 gram and saxagliptin (as saxagliptin hydrochloride) 5 milligram/1 each prolonged-release oral tablet (clinical drug) Has active ingredient False Saxagliptin Inferred relationship Existential restriction modifier
Product containing precisely metformin hydrochloride 1 gram and saxagliptin (as saxagliptin hydrochloride) 2.5 milligram/1 each prolonged-release oral tablet (clinical drug) Has active ingredient False Saxagliptin Inferred relationship Existential restriction modifier
Metformin hydrochloride + saxagliptin Has active ingredient False Saxagliptin Inferred relationship Existential restriction modifier
Product containing precisely saxagliptin 2.5 milligram/1 each conventional release oral tablet Has active ingredient False Saxagliptin Inferred relationship Existential restriction modifier 1
Product containing precisely saxagliptin 2.5 milligram/1 each conventional release oral tablet Has basis of strength substance False Saxagliptin Inferred relationship Existential restriction modifier 1
Product containing precisely saxagliptin 5 milligram/1 each conventional release oral tablet Has active ingredient False Saxagliptin Inferred relationship Existential restriction modifier 1
Product containing precisely saxagliptin 5 milligram/1 each conventional release oral tablet Has basis of strength substance False Saxagliptin Inferred relationship Existential restriction modifier 1
Saxagliptin hydrochloride Is a False Saxagliptin Inferred relationship Existential restriction modifier
Product containing precisely saxagliptin 5 milligram/1 each conventional release oral tablet Has precise active ingredient False Saxagliptin Inferred relationship Existential restriction modifier 1
Product containing precisely saxagliptin 2.5 milligram/1 each conventional release oral tablet Has precise active ingredient False Saxagliptin Inferred relationship Existential restriction modifier 1
Product containing saxagliptin in oral dose form (medicinal product form) Has active ingredient True Saxagliptin Inferred relationship Existential restriction modifier 1
Saxagliptin hydrochloride Is modification of True Saxagliptin Inferred relationship Existential restriction modifier
Saxagliptin Has active ingredient True Saxagliptin Inferred relationship Existential restriction modifier 1
Product containing only saxagliptin in oral dose form (medicinal product form) Has active ingredient True Saxagliptin Inferred relationship Existential restriction modifier 1
Product containing precisely saxagliptin (as saxagliptin hydrochloride) 2.5 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance True Saxagliptin Inferred relationship Existential restriction modifier 1
Product containing precisely saxagliptin (as saxagliptin hydrochloride) 5 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance True Saxagliptin Inferred relationship Existential restriction modifier 1
Product containing precisely metformin hydrochloride 1 gram and saxagliptin (as saxagliptin hydrochloride) 2.5 milligram/1 each prolonged-release oral tablet (clinical drug) Has basis of strength substance True Saxagliptin Inferred relationship Existential restriction modifier 2
Product containing precisely metformin hydrochloride 500 milligram and saxagliptin (as saxagliptin hydrochloride) 5 milligram/1 each prolonged-release oral tablet (clinical drug) Has basis of strength substance True Saxagliptin Inferred relationship Existential restriction modifier 2
Product containing precisely metformin hydrochloride 1 gram and saxagliptin (as saxagliptin hydrochloride) 5 milligram/1 each prolonged-release oral tablet (clinical drug) Has basis of strength substance True Saxagliptin Inferred relationship Existential restriction modifier 2
Product containing metformin and saxagliptin (medicinal product) Has active ingredient True Saxagliptin Inferred relationship Existential restriction modifier 2
Product containing metformin and saxagliptin in oral dose form (medicinal product form) Has active ingredient True Saxagliptin Inferred relationship Existential restriction modifier 2
Saxagliptin + Metformin Has active ingredient True Saxagliptin Inferred relationship Existential restriction modifier 2
Product containing only metformin and saxagliptin in oral dose form (medicinal product form) Has active ingredient True Saxagliptin Inferred relationship Existential restriction modifier 2
Product containing dapagliflozin and metformin and saxagliptin (medicinal product) Has active ingredient True Saxagliptin Inferred relationship Existential restriction modifier 2
Product containing only dapagliflozin and metformin and saxagliptin (medicinal product) Has active ingredient True Saxagliptin Inferred relationship Existential restriction modifier 2
Product containing only dapagliflozin and metformin and saxagliptin in oral dose form (medicinal product form) Has active ingredient True Saxagliptin Inferred relationship Existential restriction modifier 2
Product containing dapagliflozin and metformin and saxagliptin in oral dose form (medicinal product form) Has active ingredient True Saxagliptin Inferred relationship Existential restriction modifier 2
Onglyza 5mg tablets (Ethigen Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Saxagliptin Inferred relationship Existential restriction modifier
Onglyza 5mg tablets (Ethigen Ltd) 28 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Saxagliptin Inferred relationship Existential restriction modifier
Product containing precisely saxagliptin 2.5 milligram/1 each conventional release oral tablet Has active ingredient False Saxagliptin Inferred relationship Existential restriction modifier
Product containing precisely saxagliptin 5 milligram/1 each conventional release oral tablet Has active ingredient False Saxagliptin Inferred relationship Existential restriction modifier
Onglyza 5mg tablets (DE Pharmaceuticals) 30 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Saxagliptin Inferred relationship Existential restriction modifier
Saxagliptin 5mg tablets 30 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Saxagliptin Inferred relationship Existential restriction modifier
Onglyza 2.5mg tablets (Pharmaram Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Saxagliptin Inferred relationship Existential restriction modifier
Onglyza 2.5mg tablets (Pharmaram Ltd) 28 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Saxagliptin Inferred relationship Existential restriction modifier
Onglyza 5mg tablets (Pharmaram Ltd) 28 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Saxagliptin Inferred relationship Existential restriction modifier
Onglyza 5mg tablets (Pharmaram Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Saxagliptin Inferred relationship Existential restriction modifier
Onglyza 2.5mg tablets (CST Pharma Ltd) 28 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Saxagliptin Inferred relationship Existential restriction modifier
Komboglyze 2.5mg/1000mg tablets (Mawdsley-Brooks & Company Ltd) 56 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Saxagliptin Inferred relationship Existential restriction modifier
Onglyza 2.5mg tablets (CST Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Saxagliptin Inferred relationship Existential restriction modifier
Onglyza 5mg tablets (CST Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Saxagliptin Inferred relationship Existential restriction modifier
Komboglyze 2.5mg/1000mg tablets (Mawdsley-Brooks & Company Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Saxagliptin Inferred relationship Existential restriction modifier
Onglyza 5mg tablets (CST Pharma Ltd) 28 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Saxagliptin Inferred relationship Existential restriction modifier
Onglyza 2.5mg tablets (Mawdsley-Brooks & Company Ltd) 28 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Saxagliptin Inferred relationship Existential restriction modifier
Onglyza 2.5mg tablets (Mawdsley-Brooks & Company Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Saxagliptin Inferred relationship Existential restriction modifier
Saxagliptin 2.5mg tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Saxagliptin Inferred relationship Existential restriction modifier
Saxagliptin 5mg tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Saxagliptin Inferred relationship Existential restriction modifier
Saxagliptin 2.5mg tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance False Saxagliptin Inferred relationship Existential restriction modifier
Saxagliptin 5mg tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance False Saxagliptin Inferred relationship Existential restriction modifier
Onglyza 5mg tablets (DE Pharmaceuticals) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Saxagliptin Inferred relationship Existential restriction modifier
Onglyza 5mg tablets (DE Pharmaceuticals) 28 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Saxagliptin Inferred relationship Existential restriction modifier
Komboglyze 2.5mg/1000mg tablets (DE Pharmaceuticals) 56 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Saxagliptin Inferred relationship Existential restriction modifier
Onglyza 2.5mg tablets (DE Pharmaceuticals) 28 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Saxagliptin Inferred relationship Existential restriction modifier
Komboglyze 2.5mg/1000mg tablets (DE Pharmaceuticals) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Saxagliptin Inferred relationship Existential restriction modifier
Onglyza 2.5mg tablets (DE Pharmaceuticals) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Saxagliptin Inferred relationship Existential restriction modifier
Saxagliptin 5mg tablets 28 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Saxagliptin Inferred relationship Existential restriction modifier
Saxagliptin 5mg tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance False Saxagliptin Inferred relationship Existential restriction modifier
Onglyza 5mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Saxagliptin Inferred relationship Existential restriction modifier
Onglyza 5mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 28 tablet 2 x 14 tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Saxagliptin Inferred relationship Existential restriction modifier
Saxagliptin 5mg tablets Has active ingredient False Saxagliptin Inferred relationship Existential restriction modifier
Onglyza 5mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Has active ingredient False Saxagliptin Inferred relationship Existential restriction modifier
Product containing precisely saxagliptin 5 milligram/1 each conventional release oral tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance False Saxagliptin Inferred relationship Existential restriction modifier
Onglyza 5mg tablets (Sigma Pharmaceuticals Plc) Has active ingredient False Saxagliptin Inferred relationship Existential restriction modifier
Onglyza 5mg tablets (Sigma Pharmaceuticals Plc) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Saxagliptin Inferred relationship Existential restriction modifier
Onglyza 5mg tablets (Sigma Pharmaceuticals Plc) 28 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Saxagliptin Inferred relationship Existential restriction modifier
Onglyza 2.5mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Has active ingredient False Saxagliptin Inferred relationship Existential restriction modifier
Onglyza 5mg tablets (Mawdsley-Brooks & Company Ltd) Has active ingredient False Saxagliptin Inferred relationship Existential restriction modifier
Onglyza 5mg tablets (Mawdsley-Brooks & Company Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Saxagliptin Inferred relationship Existential restriction modifier
Onglyza 5mg tablets (Mawdsley-Brooks & Company Ltd) 28 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Saxagliptin Inferred relationship Existential restriction modifier
Onglyza 2.5mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Saxagliptin Inferred relationship Existential restriction modifier
Product containing precisely saxagliptin 2.5 milligram/1 each conventional release oral tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance False Saxagliptin Inferred relationship Existential restriction modifier
Saxagliptin 2.5mg tablets 28 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Saxagliptin Inferred relationship Existential restriction modifier
Onglyza 2.5mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 28 tablet 2 x 14 tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Saxagliptin Inferred relationship Existential restriction modifier
Onglyza 5mg tablets (Waymade Healthcare Plc) Has active ingredient False Saxagliptin Inferred relationship Existential restriction modifier
Onglyza 5mg tablets (Waymade Healthcare Plc) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Saxagliptin Inferred relationship Existential restriction modifier
Onglyza 5mg tablets (Waymade Healthcare Plc) 28 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Saxagliptin Inferred relationship Existential restriction modifier
Saxagliptin 2.5mg / Metformin 1g tablets Has active ingredient False Saxagliptin Inferred relationship Existential restriction modifier
Saxagliptin 2.5mg / Metformin 1g tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Saxagliptin Inferred relationship Existential restriction modifier
Saxagliptin 2.5mg / Metformin 850mg tablets Has active ingredient False Saxagliptin Inferred relationship Existential restriction modifier
Saxagliptin 2.5mg / Metformin 850mg tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Saxagliptin Inferred relationship Existential restriction modifier
Komboglyze 2.5mg/850mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Has active ingredient True Saxagliptin Inferred relationship Existential restriction modifier
Komboglyze 2.5mg/850mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Saxagliptin Inferred relationship Existential restriction modifier
Komboglyze 2.5mg/1000mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Has active ingredient True Saxagliptin Inferred relationship Existential restriction modifier
Komboglyze 2.5mg/1000mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Saxagliptin Inferred relationship Existential restriction modifier
Saxagliptin 2.5mg / Metformin 1g tablets 56 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Saxagliptin Inferred relationship Existential restriction modifier
Saxagliptin 2.5mg / Metformin 850mg tablets 56 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Saxagliptin Inferred relationship Existential restriction modifier
Komboglyze 2.5mg/850mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 56 tablet 7 x 8 tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Saxagliptin Inferred relationship Existential restriction modifier
Komboglyze 2.5mg/1000mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 56 tablet 7 x 8 tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Saxagliptin Inferred relationship Existential restriction modifier
Onglyza 2.5mg tablets (Waymade Healthcare Plc) Has active ingredient False Saxagliptin Inferred relationship Existential restriction modifier
Onglyza 2.5mg tablets (Waymade Healthcare Plc) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Saxagliptin Inferred relationship Existential restriction modifier
Onglyza 2.5mg tablets (Waymade Healthcare Plc) 28 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Saxagliptin Inferred relationship Existential restriction modifier
Saxagliptin hydrochloride Is a False Saxagliptin Inferred relationship Existential restriction modifier
Saxagliptin 5mg / Dapagliflozin 10mg tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Saxagliptin Inferred relationship Existential restriction modifier
Qtern 5mg/10mg tablets (AstraZeneca UK Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Saxagliptin Inferred relationship Existential restriction modifier
Saxagliptin 5mg / Dapagliflozin 10mg tablets 28 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Saxagliptin Inferred relationship Existential restriction modifier
Qtern 5mg/10mg tablets (AstraZeneca UK Ltd) 28 tablet 2 x 14 tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Saxagliptin Inferred relationship Existential restriction modifier
Saxagliptin + Dapagliflozin Has active ingredient True Saxagliptin Inferred relationship Existential restriction modifier

Page 1 of 2 End


This concept is not in any reference sets

Back to Start